Form 4 Tracker
Barry D Quart

Director · 5 filings · Latest: May 29, 2026

Kiniksa Pharmaceuticals International, plc
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
KNSA
Barry D QuartDirectorMay 29, 2026
Option Exercise
2,79915,345
KNSA
Barry D QuartDirectorApr 28, 2026
Sale
$50.1013,099$656.3K12,546
KNSA
Barry D QuartDirectorApr 28, 2026
Option Exercise
$14.3313,099$187.7K25,645
KNSA
Barry D QuartDirectorApr 6, 2026
Sale
$50.006,901$345.1K12,546
KNSA
Barry D QuartDirectorApr 6, 2026
Option Exercise
$14.336,901$98.9K19,447
KNSA
Quart Barry DApr 6, 2026
Proposed Sale
$50.0020,000$1.0M
KNSA
Barry D QuartDirectorFeb 12, 2026
Sale
$45.002,690$121.0K12,546
KNSA
Barry D QuartDirectorFeb 12, 2026
Option Exercise
$15.472,690$41.6K15,236
KNSA
Barry D QuartDirectorFeb 10, 2026
Sale
$45.00110$5.0K12,546
KNSA
Barry D QuartDirectorFeb 10, 2026
Option Exercise
$15.47110$1.7K12,656
KNSA
Barry D QuartDirectorFeb 4, 2026
Sale
$45.022,602$117.1K12,546
KNSA
Barry D QuartDirectorFeb 4, 2026
Option Exercise
$15.472,602$40.3K15,148
KNSA
Barry D QuartDirectorFeb 3, 2026
Sale
$45.2712,528$567.1K12,546
KNSA
Barry D QuartDirectorFeb 3, 2026
Option Exercise
$15.4712,528$193.8K25,074
KNSA
Barry D QuartDirectorFeb 2, 2026
Sale
$45.00830$37.4K12,546
KNSA
Barry D QuartDirectorFeb 2, 2026
Option Exercise
$15.47830$12.8K13,376
KNSA
Quart Barry DDec 15, 2025
Proposed Sale
$41.5158,889$2.4M
KNSA
Quart Barry DJun 9, 2025
Proposed Sale
$30.2627,448$830.6K